Study of Stimulus Parameters in Flicker Electroretinogram (ERG)

Sponsor
LKC Technologies, Inc. (Industry)
Overall Status
Unknown status
CT.gov ID
NCT02466607
Collaborator
(none)
20
1
2
4
5

Study Details

Study Description

Brief Summary

The electroretinogram (ERG) is a diagnostic test that measures the electrical activity generated by cells in the retina in response to a light stimulus. Typically, an ERG is recorded with white flash when the pupil is dilated. RETeval Visual Diagnostic Device (RETeval) generates an array of color flashes, which allows studying whether color flash would be a useful diagnostic tool.

Full pupil dilation is required to obtain a response from the whole retina. However, this requirement often limits a patient's flow in the clinic and increases the overall time patients spend at the eye practitioner. RETeval provides the possibility of recording ERGs in un-dilated pupils therefore making the whole exam easier and shorter. These results need to be compared to the classic, fully dilated ERG and evaluated for efficiency.

The purpose of this research study is to use the RETeval device to measure the eye's electrical response and how it changes with different stimuli such as changing flash color or pupil dilation.

Condition or Disease Intervention/Treatment Phase
  • Device: RETeval color flicker ERG
  • Device: RETeval dilated versus un-dilated flicker ERG
  • Other: pupil dilation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Study of Stimulus Parameters in Flicker Electroretinogram (ERG)
Study Start Date :
Mar 1, 2015
Anticipated Primary Completion Date :
Jul 1, 2015
Anticipated Study Completion Date :
Jul 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Other: RETeval color flicker ERG

Compare implicit times and amplitudes of electroretinograms obtained from series of color flashes to those obtained from white flashes.

Device: RETeval color flicker ERG
Flicker ERGs obtained to 56 CIE 1931 (created by the International Commission on Illumination (CIE) in 1931) colors series. White flash of 0,33, 0,33 was used for comparison.

Other: RETeval dilated versus un-dilated flicker ERG

Compare implicit times and amplitudes of ERGs obtained from cd/m2/sec stimulation (used with dilated pupils) to those obtained from troland stimulation (used with un-dilated pupils).

Device: RETeval dilated versus un-dilated flicker ERG
Two series of white flashes: 3,0 cd/m2/sec and Trolands equivalent assuming 3,7 mm pupil size, delivered at 3 min interval over 30 min.

Other: pupil dilation
Pupil will be dilated using Proparacaine 0.5% and Tropicamide 0.5%

Outcome Measures

Primary Outcome Measures

  1. Flicker harmonic amplitude [up to 2 mnths]

  2. Flicker harmonic implicit time [up to 2 months]

  3. Flicker fundamental amplitude [up to 2 months]

  4. Flicker fundamental implicit time [up to 2 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy adult volunteers

  • volunteers able to get their pupil fully dilated

Exclusion Criteria:
  • pregnant women

  • children

  • subjects with

  • light sensitivity

  • photosensitive epilepsy

  • allergies or sensitivity to pupil dilation ophthalmic solutions

  • history of glaucoma

  • cardiac dysrhythmia will not be invited to participate in this study.

  • Pregnancy status, light sensitivity and photosensitive epilepsy will be based on volunteer's providing this information at the time of signing the consent form

Contacts and Locations

Locations

Site City State Country Postal Code
1 Wedgwood Optometry Fort Worth Texas United States 76133

Sponsors and Collaborators

  • LKC Technologies, Inc.

Investigators

  • Principal Investigator: Olga Kraszewska, Ph.D., LKC Technologies

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
LKC Technologies, Inc.
ClinicalTrials.gov Identifier:
NCT02466607
Other Study ID Numbers:
  • SAIRB-15-0017
First Posted:
Jun 9, 2015
Last Update Posted:
Jun 9, 2015
Last Verified:
Jun 1, 2015
Keywords provided by LKC Technologies, Inc.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 9, 2015